First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Up 33.3% in January

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the target of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 1,200 shares, an increase of 33.3% from the January 15th total of 900 shares. Based on an average daily volume of 2,900 shares, the short-interest ratio is currently 0.4 days.

Institutional Investors Weigh In On First Trust Nasdaq Pharmaceuticals ETF

Institutional investors have recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. grew its position in First Trust Nasdaq Pharmaceuticals ETF by 17.0% during the fourth quarter. Envestnet Asset Management Inc. now owns 16,403 shares of the company’s stock valued at $442,000 after acquiring an additional 2,384 shares during the period. Ameritas Investment Partners Inc. grew its position in First Trust Nasdaq Pharmaceuticals ETF by 13.0% during the fourth quarter. Ameritas Investment Partners Inc. now owns 14,173 shares of the company’s stock valued at $382,000 after acquiring an additional 1,633 shares during the period. Finally, LPL Financial LLC lifted its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 9.3% during the fourth quarter. LPL Financial LLC now owns 55,876 shares of the company’s stock worth $1,507,000 after purchasing an additional 4,776 shares in the last quarter.

First Trust Nasdaq Pharmaceuticals ETF Stock Down 1.4 %

Shares of NASDAQ:FTXH traded down $0.38 during midday trading on Friday, reaching $27.25. The company’s stock had a trading volume of 455 shares, compared to its average volume of 3,332. The firm has a market cap of $13.63 million, a price-to-earnings ratio of 15.98 and a beta of 0.70. First Trust Nasdaq Pharmaceuticals ETF has a 1 year low of $25.73 and a 1 year high of $29.72. The business has a 50 day moving average price of $27.31 and a 200 day moving average price of $28.15.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The company also recently declared a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Friday, December 13th were given a dividend of $0.1304 per share. The ex-dividend date of this dividend was Friday, December 13th. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.